Johnson & Johnson (JNJ) sees FDA revoke authorization of Janssen COVID-19 vaccine

02 Jun 2023 - 21:06- Equities- Source: Newswires

Johnson & JohnsonPharmaceuticals (Group)PharmaceuticalsPharmaceuticals, Biotechnology & Life SciencesJNJ.USJNJFDAEquitiesS&P 500 IndexAsian Session

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: